Key predictors of progressive lung disease in ASSD include the presence of non-Jo-1 autoantibodies such as anti-PL7 and anti-PL12, male sex, older age, low diffusion capacity (DLCO) at diagnosis, and the co-occurrence of anti-Ro52 antibodies. The gene discussed is TRIM21; the disease is lung disorder.